<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group</title>
	<atom:link href="http://www.ovariancancer.org/2010/01/22/evaluation-of-pemetrexed-alimta-ly231514-as-second-line-chemotherapy-in-persistent-or-recurrent-carcinoma-of-the-cervix-the-cervix-1-study-of-the-mito-multicentre-italian-trials-in-ovarian-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.ovariancancer.org/2010/01/22/evaluation-of-pemetrexed-alimta-ly231514-as-second-line-chemotherapy-in-persistent-or-recurrent-carcinoma-of-the-cervix-the-cervix-1-study-of-the-mito-multicentre-italian-trials-in-ovarian-cancer/</link>
	<description>We work to save women&#039;s lives</description>
	<lastBuildDate>Tue, 07 Sep 2010 16:25:14 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk (feed is rejected)
Page Caching using disk (enhanced)

Served from: www.ovariancancer.org @ 2010-09-10 20:28:54 -->